E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/20/2006 in the Prospect News Biotech Daily.

Connetics on hold by Jefferies

Jefferies & Co., Inc. analyst David Windley maintained Connetics Corp. at a hold and $6.50 price target after management met with limited success in convincing the convertible holders to agree to amended terms. Connetics has extended the deadline of consent solicitation for its convertible notes (due 2008 and 2015). The holders of the 2015 notes (face value $200 million) have not yet agreed to the amended terms and may force early repayment of these notes. Shares of the Palo Alto, Calif.-based specialty pharmaceutical company were up 20 cents, or 2.44%, at $8.41 on volume of 712,160 shares versus the three-month running average of 779,323 shares. (Nasdaq: CNCT)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.